换一批Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, methotrexate, etoposide and dexamethasone (ACOMED) followed by involved field radiotherapy induces high remission rates and durable long-term survival in patients with aggressive malignant non-Hodgkin's lymphomas: long-term follow-up of a pilot study.
第一作者：
Susanne,Rödel
第一单位：
Department I of Internal Medicine, University of Cologne, Germany.
作者：
医学主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);综合疗法(Combined Modality Therapy);环磷酰胺(Cyclophosphamide);地塞米松(Dexamethasone);多柔比星(Doxorubicin);依托泊甙(Etoposide);女(雌)性(Female);人类(Humans);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);男(雄)性(Male);甲氨蝶呤(Methotrexate);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);放射疗法(Radiotherapy);存活率分析(Survival Analysis);幸存患者(Survivors);长春新碱(Vincristine)
DOI
10.1080/10428190500215225
PMID
16353313
发布时间
2019-11-09
- 浏览34
Leukemia & lymphoma
1729-34页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
